RGC insider trading
NasdaqCM HealthcareREGAL ENTERTAINMENT GROUP — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About REGAL ENTERTAINMENT GROUP
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Company website: www.regencellbioscience.com
RGC insider activity at a glance
FilingIQ has scored 186 insider transactions for RGC since Jan 8, 2015. The most recent filing in our index is dated May 27, 2026.
Across the full history, 4 open-market purchases
and 10 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on RGC insider trades is 68.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Politicians who have traded RGC
Frequently asked
- How many insider trades does FilingIQ track for RGC?
- FilingIQ tracks 186 Form 4 insider transactions for RGC (REGAL ENTERTAINMENT GROUP), covering filings from Jan 8, 2015 onwards. 2 of those were filed in the last 90 days.
- Are RGC insiders net buyers or net sellers?
- Across the full Form 4 history for RGC, 4 transactions (2%) were open-market purchases and 10 (5%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does RGC insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is RGC in?
- REGAL ENTERTAINMENT GROUP (RGC) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $3.20B.
Methodology & sources
Every RGC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.